WallStreetZenWallStreetZen

NASDAQ: YS
Ys Biopharma Co Ltd Earnings & Revenue

YS earnings and revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

YS Return on Equity

Insufficient data to display

Be the first to know when YS announces earnings.

YS Return on Assets

Current Company
N/A
Current Industry
2.9%

YS Return on Capital Employed

Current Company
0%
Current Industry
19.5%

YS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
YSN/AN/AN/AN/AN/A
CNTB$0.00-$59.36M-$59.50MN/AN/A
ATHA$0.00-$116.49M-$117.67MN/AN/A
PASG$0.00-$98.34M-$102.06MN/AN/A
CGTX$0.00-$25.51M-$25.79MN/AN/A

Ys Biopharma Co Earnings & Revenue FAQ

What were YS's earnings last quarter?

Ys Biopharma Co (NASDAQ: YS) reported Q4 2023 earnings per share (EPS) of -$0.83, up 3.49% year over year. Total Ys Biopharma Co earnings for the quarter were -$77.77 million. In the same quarter last year, Ys Biopharma Co's earnings per share (EPS) was -$0.86.

If you're new to stock investing, here's how to buy Ys Biopharma Co stock.

What was YS's earnings growth in the past year?

As of Q2 2024, Ys Biopharma Co's earnings has grown year over year. Ys Biopharma Co's earnings in the past year totalled N/A.

What was YS's revenue last quarter?

Ys Biopharma Co (NASDAQ: YS) reported Q4 2023 revenue of $164.98 million up 9.18% year over year. In the same quarter last year, Ys Biopharma Co's revenue was $181.65 million.

What was YS's revenue growth in the past year?

As of Q2 2024, Ys Biopharma Co's revenue has grown null year over year. Ys Biopharma Co's revenue in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.